AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Thursday, April 4, 2019

In The News

AACC Alert

CLN Connect

Whether a lab is implementing antinuclear antibody (ANA) testing for the first time or moving to a newer methodology, the facility should consider several key factors involving the method’s diagnostic utility and performance characteristics, Melissa R. Snyder, PhD writes in the April Clinical Laboratory News.

Inside AACC

Advancing applications of mass spectrometry (MS) are extending beyond biofluids into tissue analysis. Clinical laboratories have taken notice of MS’ ability to identify a variety of biomolecules in tissue samples. One technique, matrix-assisted laser desorption/ionization (MALDI) MS, analyzes thin tissue sections in a nontargeted manner to assess abundance and spatial…

Practice Management

World View